Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cystic Fibrosis
100%
Obstructive Sleep Apnea
73%
Asthma
63%
Pediatric Obstructive Sleep Apnea
39%
Lung Transplantation
38%
Primary Ciliary Dyskinesia
33%
Pediatric Lung Transplantation
26%
Pediatric
22%
Sleep-disordered Breathing
20%
Cystic Fibrosis Transmembrane Conductance Regulator
20%
Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS)
18%
Inhaled Corticosteroids
18%
Preschool children
17%
Apnea-hypopnea Index
15%
Obesity
15%
Forced Expiratory Volume in 1 Second (FEV1)
14%
Wheezing
14%
Allergic Diseases
14%
Intermittent Hypoxia
13%
Asthma Exacerbation
13%
Lung Function
13%
Polysomnography
13%
Childhood Asthma
13%
Epithelial Sodium Channel (ENaC)
12%
Airway
11%
Placebo
11%
Oximetry
11%
United States
11%
Clinical Trials
11%
Lung
11%
95% Confidence Interval
11%
Obese children
10%
Adenotonsillectomy
9%
Children with Asthma
9%
Environmental Influences on Child Health Outcomes
9%
Risk Factors
9%
Inflammation
9%
Elexacaftor-tezacaftor-ivacaftor
9%
SpO2
9%
Sleep Apnea
8%
Young children
8%
High Risk
8%
Airway Epithelial Cells
8%
Genotype
8%
Azithromycin
8%
Allergen
8%
Body Mass Index
8%
Transplantation
7%
Pediatric Patients
7%
Recurrent Wheezing
7%
Sleep Apnea Syndrome
7%
Allergy
7%
Endothelial Dysfunction
7%
Atopy
7%
Meta-analysis
7%
COVID-19
7%
Severe Asthma
7%
Gene Transfer
7%
Snoring
7%
Endothelial Function
7%
Allergic Asthma
7%
Allergic Rhinitis
7%
Pancreatic Insufficient
7%
School-age children
7%
Pediatric Asthma
6%
Bronchiolitis Obliterans
6%
Vitamin D
6%
Cilia
6%
Airway Inflammation
6%
Fluticasone Propionate
6%
Asthma Control
6%
Eosinophils
6%
Pulmonary Function
6%
Non-obese children
6%
Epithelial Cells
6%
Moderate to Severe
6%
Post-transplant Lymphoproliferative Disorder
6%
Exosomes
6%
Cystic Fibrosis Lung Disease
6%
Montelukast
6%
Virus
6%
Pseudomonas Aeruginosa (P. aeruginosa)
5%
Pediatric Pulmonary
5%
Cystic Fibrosis Foundation
5%
Airflow
5%
Upper Airway
5%
Caregivers
5%
Recurrent Wheeze
5%
Gene Expression
5%
Excessive Daytime Sleepiness
5%
Ivacaftor
5%
Sleep Disorders
5%
Plasma Parameters
5%
Respiratory Infection
5%
Rhinovirus
5%
Randomized Placebo-controlled Trial
5%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
5%
Severe Asthma Research Program
5%
Percent Predicted
5%
Clinical Outcomes
5%
Medicine and Dentistry
Pediatrics
95%
Cystic Fibrosis
83%
Obstructive Sleep Apnea
79%
Asthma
72%
Lung Transplantation
52%
Lung
43%
Diseases
34%
Wheeze
24%
Primary Ciliary Dyskinesia
23%
Corticosteroid
18%
Silo-Filler's Disease
17%
Hypopnea
15%
Morbidity
15%
Apnea
14%
Preschooler
13%
Patient with Cystic Fibrosis
13%
Infection
12%
Body Mass Index
11%
Adolescence
11%
Placebo
11%
Oral
11%
Inflammation
11%
Ivacaftor
11%
Oximetry
11%
Polysomnography
10%
Adenotonsillectomy
10%
Bronchiolitis Obliterans
10%
Respiratory Disease
9%
Genetics
9%
Breathing
9%
Prevalence
9%
Clinical Trial
9%
Cystic Fibrosis Transmembrane Conductance Regulator
9%
Glucose
8%
Tezacaftor
8%
Forced Expiratory Volume
8%
Vitamin D
8%
Pediatrics Patient
8%
Lung Function
8%
Sudden Infant Death Syndrome
8%
Biological Marker
7%
Health Outcomes
7%
Child Health
7%
Nitric Oxide
7%
Sensitization
7%
Environmental Influence
7%
Glucose Tolerance
6%
Systematic Review
6%
Montelukast
6%
Meta-Analysis
6%
Prematurity
6%
Pulmonary Hypertension
5%
Human Respiratory Syncytial Virus
5%
COVID-19
5%
In Vitro
5%
Azithromycin
5%
Asthma Exacerbation
5%
Sleep Time
5%
Serositis
5%
Allergic Rhinitis
5%
Cohort Analysis
5%
Arm
5%
Allograft
5%
Atopy
5%
Insulin
5%
Posttransplant Lymphoproliferative Disease
5%
Pathogenesis
5%
Bronchiolitis
5%
Severe Asthma
5%
Immunology and Microbiology
Asthma
98%
Lung
34%
Airway
31%
Lung Transplantation
30%
Infection
24%
Infectious Disease
24%
Allergen
17%
Severe Asthma
17%
Inflammation
16%
Immunoglobulin E
15%
Allergic Asthma
13%
Asthma Exacerbation
12%
Morbidity
12%
Adolescence
10%
Bronchiolitis
10%
Sensitization
9%
Blood Plasma
9%
Breathing
9%
Atopy
8%
In Vitro
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Pseudomonas aeruginosa
8%
T Cell
8%
Viral Disease
7%
Allergic Rhinitis
7%
Blood Level
7%
C-Reactive Protein
7%
Neutrophil
7%
Gene Expression
6%
Immunotherapy
6%
Virus
6%
Body Mass
6%
Lung Function
6%
Prevalence
6%
Cardiovascular System
6%
Forced Expiratory Volume
6%
Sputum
6%
Rhinovirus
6%
Eosinophil
6%
Gene Transfer
6%
Inflammation Response
6%
B Cell
5%
Immune Response
5%
Cytokine
5%
Omalizumab
5%
Human Respiratory Syncytial Virus
5%
Cystic Fibrosis Transmembrane Conductance Regulator
5%
Microbiome
5%
Airflow
5%
Dendritic Cell
5%
Plasmacytoid Dendritic Cell
5%